Analyst Price Targets — CNTA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 23, 2026 9:07 pm | — | Wolfe Research | $40.00 | $25.49 | TheFly | Centessa initiated with an Outperform at Wolfe Research |
| January 29, 2026 2:25 pm | — | Truist Financial | $38.00 | $24.73 | TheFly | Centessa price target raised to $38 from $33 at Truist |
| January 8, 2026 12:54 pm | Danielle Brill | Truist Financial | $33.00 | $22.69 | TheFly | Centessa price target raised to $33 from $30 at Truist |
| January 5, 2026 12:24 pm | — | Needham | $38.00 | $23.69 | TheFly | Centessa price target raised to $38 from $35 at Needham |
| December 1, 2025 11:57 am | Mayank Mamtani | B.Riley Financial | $42.00 | $28.72 | StreetInsider | Centessa Pharmaceuticals (CNTA) PT Raised to $42 at B.Riley |
| November 5, 2025 1:03 pm | Danielle Brill | Truist Financial | $30.00 | $19.15 | StreetInsider | Truist Securities Comments on Centessa Pharmaceuticals (CNTA) Amid 18pct Drop |
| October 28, 2025 7:55 am | Sudan Loganathan | Stephens | $35.00 | $24.46 | StreetInsider | Stephens Starts Centessa Pharmaceuticals (CNTA) at Overweight |
| September 2, 2025 8:43 pm | — | Wells Fargo | $31.00 | $17.27 | TheFly | Centessa initiated with an Overweight at Wells Fargo |
| May 8, 2025 2:42 pm | Andreas Argyrides | Oppenheimer | $6.00 | $12.41 | Benzinga | This Centessa Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Thursday |
| May 8, 2025 2:42 pm | Rudy Li | Chardan Capital | $30.00 | $12.41 | Benzinga | This Centessa Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Thursday |
Latest News for CNTA
Pre-Market Stock Futures: Futures are trading lower this morning after negotiations with Iran failed over the weekend, and President Trump indicated the U.S. will block the Strait of Hormuz. This comes as we get set to start the first-quarter earnings season this week, as the major money-center banks and brokerage firms begin to report results... Here Are Monday's Top Wall Street Analyst Research Calls: Adobe, Best…
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
MILWAUKEE, April 07, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Centessa (NASDAQ: CNTA) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Lilly.
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ: CNTA - Get Free Report)'s stock price hit a new 52-week high during mid-day trading on Tuesday. The company traded as high as $40.00 and last traded at $40.0980, with a volume of 3519760 shares trading hands. The stock had previously closed at $27.58. Trending Headlines about Centessa Pharmaceuticals
NEW YORK, April 1, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Centessa Pharmaceuticals plc (NASDAQ:…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CNTA.
U.S. House Trading
No House trades found for CNTA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.